Represented a clinical-stage pharmaceutical company in its US$80m initial public offering of common stock through a syndicate of underwriters led by Jefferies and Piper Jaffray.*
Stephen M. Nicolai
As a senior associate in our Corporate Practice Group, Stephen Nicolai uses a practical, business-minded approach to counsel both public and private companies on issues that arise in securities offerings, mergers and acquisitions, securities law compliance, and corporate governance matters.
Stephen has a well-rounded corporate practice and experience with public and private M&A transactions, debt and equity financings, and a broad range of legal matters, including governance, fiduciary duties, and organizational matters. He advises clients across several industries, with a focus and a passion for the life sciences.
Before joining Hogan Lovells, Stephen worked as an associate for another large law firm in Philadelphia, where he advised clients on a range of corporate and securities matters. While in law school at Villanova University School of Law, Stephen served as the Managing Editor of Operations of the Villanova Law Review.
Represented a clinical-stage biopharmaceutical company in its US$40m at-the-market equity program led by Cowen and Company.*
Represented a clinical-stage biopharmaceutical company in a US$225m public offering of common stock through a syndicate of underwriters led by J.P. Morgan and Goldman Sachs.*
Regularly advises public companies on a range of corporate governance and securities matters, including fiduciary duties, periodic reports, Section 16 compliance, annual meetings and proxy statements.
*Matter handled prior to joining Hogan Lovells.